Low doses of dexamethasone affect immune parameters in the absence of immunological stimulation

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 6, 2006, Pages 322-328

  Schuld, Andreas ^a,b   Birkmann, S ^a   Beitinger, P ^a   Haack, M ^a   Kraus, T ^a   Dalal, M A ^a   Holsboer, F ^a   Pollmacher T ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b KLINIKUM INGOLSTADT   (Germany)

Author keywords

Glucocorticoids; Hypothalamo pituitary adrenal system; Tumor necrosis factor

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; PLACEBO; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR P55; TUMOR NECROSIS FACTOR RECEPTOR P75; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LEUKOCYTE DIFFERENTIAL COUNT; LOW DRUG DOSE; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TYMPANIC TEMPERATURE;

ADMINISTRATION, ORAL; ADULT; BODY TEMPERATURE; CIRCADIAN RHYTHM; CYTOKINES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EAR; HUMANS; HYDROCORTISONE; IMMUNE SYSTEM; IMMUNIZATION; LEUKOCYTE COUNT; MALE; PLACEBOS; RECEPTORS, CYTOKINE;

EID: 33746696703     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924255     Document Type: Article

References (28)

1. Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, Moldawer LL, Lowry SF. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993; 150: 1999-2006
2. Bleeker MW, Netea MG, Kullberg BJ, van der Ven Jongekrijg JM, van der Meer JW. The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers. Immunology 1997;91:548-552
3. Bornstein SR, Chrousos GP. Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab 1999; 84: 1729-1736
4. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351-1362
5. Dandona P, Aljada A, Garg R, Mohanty P. Increase in plasma interleukin-10 following hydrocortisone injection. J Clin Endocrinol Metab 1999; 84: 1141-1144
6. DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, Paciotti G, Gold PW, Sternberg EM. Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab 1997; 82: 2182-2191
7. Dhabhar FS, Miller AH, Stein M, McEwen BS, Spencer RL. Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations. Brain Behav Immun 1994; 8: 66-79
8. Friess E, Wiedemann K, Steiger A, Holsboer F. The hypothalamic-pituitary- adrenocortical system and sleep in man. Adv Neuroimmunol 1999; 5: 111-125
9. Gudewill S, Pollm̈cher T, Vedder H, Schreiber W, Fassbender K, Holsboer F. Nocturnal plasma levels of cytokines in healthy men. Eur Arch Psychiatry Clin Neurosci 1992; 242: 53-56
10. Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kühn M, Schuld A, Pollmächer T. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 1999; 33: 407-418
11. Haack M, Kraus T, Schuld A, Dalal M, Koethe D, Pollmächer T. Diurnal variations of interleukin-6-plasma levels during sleep and wakefulness are confounded by particularities of blood drawing. Psychoneuroendocrinology 2002; 27: 921-931
12. Haack M, Reichenberg A, Kraus T, Schuld A, Yirmiya R, Pollmächer T. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men. Cytokine 2000; 12: 694-698
13. Haus E, Smolensky MH. Biologic rhythms in the immune system. Chronobiol Int 1999; 16: 581-622
14. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 1999; 33: 181-214
15. Jilma B, Stohlawetz P, Pernerstorfer T, Eichler HG, Müllner C, Kapiotis S. Glucocorticoids dose-dependently increase plasma levels of granulocyte colony stimulating factor in man. J Clin Endocrinol Metab 1998; 83: 1037-1040
16. Maes M. Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999; 461: 25-46
17. Mullington J, Korth C, Hermann DM, Orth A, Galanos C, Holsboer F, Pollmächer T. Dose-dependent effects of endotoxin on human sleep. Am J Physiol 2000; 278: R947-R955
18. Petrovsky N, Harrison LC. The chronobiology of human cytokine production. Int Rev Immunol 1998; 16: 635-649
19. Pollmächer T, Haack M, Schuld A, Kraus T, Hinze-Seich D. Effects of antipsychotic drugs on cytokine networks. J Psychiatr Res 2000; 34: 369-382
20. Pollmächer T, Haack M, Schuld A, Reichenberg A, Yirmiya R. Low levels of circulating inflammatory cytokines - do they affect human brain functions? Brain Behav Immun 2002; 16: 525-532
21. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmächer T. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001; 58: 445-452
22. Schuld A, Kraus T, Haack M, Hinze-Seich D, Zobel AW, Holsboer F, Pollmächer T. Effects of dexamethasone on cytokine plasma levels and white blood cell counts in depressed patients. Psychoneuroendocrinology 2001; 26: 65-76
23. Schuld A, Mullington J, Friess E, Hermann DM, Galanos C, Holsboer F, Pollmächer T. Changes in dehydroepiandrosterone (DHEA) and DHEA-sulfate plasma levels during experimental endotoxinemia in healthy volunteers. J Clin Endocrinol Metab 2000; 85: 4624-4629
24. Schuld A, Mullington J, Hermann DM, Hinze-Selch D, Fenzel T, Holsboer F, Pollmächer T. Effects of granulocyte colony-stimulating factor on night sleep in humans. Am J Physiol 1999; 276 (4 Pt 2): R1149-R1155
25. Schuld A, Schmid DA, Haack M, Holsboer F, Friess E, Pollmächer T. Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not cytokine responses to hydrocortisone. J Psychiatr Res 2003; 37: 463-470
26. Uhr M, Holsboer F, Müller MB. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-Glycoproteins. J Neuroendocrinol 2002; 14: 753-759
27. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, Prolo P, Wong ML, Licinio J, Gold PW, Hermida RC, Mastorakos G, Chrousos GP. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 1999; 84: 2603-2607
28. Vgontzas AN, Bixler EO, Tan TL, Kantner D, Martin LF, Kales A. Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med 1998; 158: 1333-1337